Interaction between hydrophilic drug and α-cyclodextrins: Physico-chemical aspects

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 57, Issue 1-4, 2007, Pages 211-217

  Lahiani Skiba, Malika ^a   Boulet, Yannick ^a   Youm, Ibrahima ^a   Bounoure, Fréderic ^a   Vérité, Philippe ^a   Arnaud, Philippe ^a   Skiba, Mohamed ^a  

^a UNIVERSITÉ DE ROUEN   (France)

Author keywords

Cyclodextrins; Cysteamine; Hydrophilic drug; Organoleptic features

Indexed keywords

EID: 34047109063     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-006-9194-y     Document Type: Conference Paper

References (13)

1. Saenger, W.: Cyclodextrin inclusion compounds in research and industry. Angew. Chem. Int. Ed. Engl. 19, 344-362 (1980).
2. Rajewski, R.A., Stella, V.J.: Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. J. Pharm. Sci. 85(11), 1142-1169 (1996).
3. Loftsson, T., Brewster, M.E.: Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 85(10), 1017-1025 (1996).
4. Lach, J.L., Chin, T.F.: Inhibition of hydrolysis by means of molecular complex formation. J. Pharm. Sci. 53, 924 (1964).
5. Frömming, K.H., Sandman, R., Weyermann, I.: Stabilitäts- probleme bei der Verarbeitung von Einschluβverbindungen der Desoxycholsäure und des β-Cyclodextrins in Arzneiformen. Dtsch. Apoth.-Ztg, 112, 707 (1972).
6. Haeberlin, B., Gengenbacher, T., Meinzer, A., Fricker, G.: Cyclodextrins, useful excipients for oral peptide administration? Int. J. Pharm. 137, 103-110 (1996).
7. Uekama, K., Horikawa, T., Yamanaka, M., Hirayama, F.: Peracylated β-cyclodextrins as novel sustained-release carriers for a water-soluble drug, Molsidomine. J. Pharm. Pharmacol. 4, 714-717 (1994).
8. Andersen, F.M., Bundgaard, H., Mengel, H.B.: Formation, bioavailability and organoleptic properties of an inclusion complex of femoxetine with β-cyclodextrin. Int. J. Pharm. 21, 51-60 (1984).
9. Skiba, M., Fessi, H., and Puisieux, F. French Patent No 94.02.312 (1994).
10. Uekama, K., Oh, K., Otagiri, M., Seo, H., Tsuruoka, M.: Improvement of some pharmaceutical properties of clofibrate by cyclodextrin complexation. Pharm. Acta Helv. 58(12), 338-342 (1983).
11. Miyaji, T., Inoue, Y., Acartürk, F., Imai, T., Otagiri, M., Uekama, K.: Improvement of oral bioavailability of fenbufen by cyclodextrin complexations. Acta Pharm. Nord. 4(1), 17-22 (1992).
12. Gal-Füzy, M., Szente, L., Szejtli, J., Harrangi, J.: Cyclodextrin stabilized volatile substances for inhalation therapy. Pharmazie, 39, 558-559 (1984).
13. Hou, S., Wang, P.: The preparation of inclusion compound of ranitidine - β?cyclodextrin. Chinese Pharm. J. 31(8), 479-481 (1996).